Athos, Cleveland Clinic to partner on IBD research

By The Science Advisory Board staff writers

August 25, 2021 -- Athos Therapeutics and the Cleveland Clinic have agreed to collaborate on inflammatory bowel disease (IBD) research. The agreement will advance the use of systems biology and computational science for precision medicine in inflammatory bowel diseases, including Crohn's disease and ulcerative colitis.

Using a systems biology approach can enable clinicians to properly characterize the heterogeneity of the disease at the molecular level, the companies believe. From there, IBD patients can be classified into specific molecular subtypes, enabling the development of custom-made therapies.

Financial details of the collaboration were not disclosed.


Copyright © 2021 scienceboard.net
 

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:



Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Email Preferences



Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.